BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 117 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $668,600 | +23.9% | 94,435 | +23.2% | 0.01% | +16.7% |
Q2 2023 | $539,700 | -53.9% | 76,662 | -17.5% | 0.01% | -76.0% |
Q3 2022 | $1,170,000 | +358.8% | 92,879 | +286.0% | 0.02% | +257.1% |
Q2 2022 | $255,000 | -86.5% | 24,061 | -81.6% | 0.01% | -77.4% |
Q3 2021 | $1,883,000 | +89.4% | 131,066 | +108.4% | 0.03% | +63.2% |
Q2 2021 | $994,000 | +68.8% | 62,898 | +8.6% | 0.02% | +58.3% |
Q1 2021 | $589,000 | +501.0% | 57,917 | +18.0% | 0.01% | +33.3% |
Q1 2020 | $98,000 | -81.4% | 49,102 | -67.9% | 0.01% | -62.5% |
Q4 2019 | $528,000 | +212.4% | 153,107 | +158.9% | 0.02% | +300.0% |
Q3 2019 | $169,000 | +20.7% | 59,148 | +60.4% | 0.01% | +50.0% |
Q2 2019 | $140,000 | -73.9% | 36,867 | -64.0% | 0.00% | -71.4% |
Q3 2017 | $537,000 | +130.5% | 102,494 | +144.5% | 0.01% | +100.0% |
Q2 2017 | $233,000 | +375.5% | 41,928 | +276.5% | 0.01% | +600.0% |
Q3 2016 | $49,000 | +4.3% | 11,137 | -33.3% | 0.00% | 0.0% |
Q2 2016 | $47,000 | -86.8% | 16,687 | -86.7% | 0.00% | -88.9% |
Q1 2016 | $355,000 | +208.7% | 125,588 | +1022.8% | 0.01% | +200.0% |
Q4 2015 | $115,000 | -65.9% | 11,185 | -62.1% | 0.00% | -72.7% |
Q3 2015 | $337,000 | +69.3% | 29,535 | +121.9% | 0.01% | +83.3% |
Q2 2015 | $199,000 | – | 13,308 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management II, LLC | 6,071,142 | $38,430,000 | 18.43% |
RTW INVESTMENTS, LP | 4,078,895 | $25,819,000 | 9.72% |
VHCP Management, LLC | 1,155,104 | $7,312,000 | 7.86% |
RA Capital Management | 2,989,795 | $18,925,000 | 2.68% |
DLD Asset Management, LP | 1,258,700 | $7,967,000 | 2.61% |
Avoro Capital Advisors LLC | 1,631,502 | $10,327,000 | 2.09% |
Ghost Tree Capital, LLC | 1,150,000 | $7,280,000 | 1.75% |
GREAT POINT PARTNERS LLC | 725,000 | $4,589,000 | 0.94% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,237,734 | $20,495,000 | 0.84% |
Baker Brothers Advisors | 10,963,944 | $69,402,000 | 0.68% |